Navigation Links
Genmab A/S - Notice to Convene Annual General Meeting
Date:4/7/2008

27 divided into shares of DKK 1 each or any multiple hereof. Each share amount of DKK 1 shall entitle the shareholder to one vote.

__________

No later than 8 days before the Annual General Meeting the agenda, the complete proposals as well as the Annual Report will be made available to the Company's shareholders at the Company's offices at Toldbodgade 33, 1253 Copenhagen K, Denmark. The documents are also available at the Company's website, http://www.genmab.com.

Admission card: Any shareholder is entitled to attend the Annual General Meeting after having submitted a request for an admission card no later than Monday April 21, 2008 at 4:00 PM CEST. Admission cards may be requested by contacting VP Investor Services A/S, telephone +45-43-58-88-66 or fax +45-43-58-88-67. Alternatively via http://www.genmab.com or http://www.uk.vp.dk/agm.

Shareholders who do not expect to be able to participate in the General Meeting may grant proxy to the Board of Directors or to a person appointed by the shareholder. A form for submitting votes by proxy may be obtained via http://www.genmab.com. The shareholders exercise their financial rights through their own deposit banks, cf. Section 73,5(2) of the Danish Public Companies Act.

Any shareholder, to whom admission card already has been issued, but who is prevented from attending the Annual General Meeting is kindly asked to notify the company - preferably before Tuesday April 22, 2008.

Copenhagen, April 7, 2008 On behalf of the Board of Directors

MICHAEL B. WIDMER Chairman

About Genmab A/S

Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for unmet medical needs. Using cutting-edge antibody technology, Genmab's
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Genmabs 2007 Annual Report
2. Genmab Announces Year End 2007 Financial Results
3. Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility
4. Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets
5. Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility
6. Medarex Announces Completion of Sale of Shares in Genmab A/S
7. Genmabs Financial Calendar for 2008
8. Genmab Reaches Milestones in Ofatumumab Collaboration
9. Genmab Announces HuMax-CD32b Pre-Clinical Program
10. Roche Files IND for Second Genmab Antibody
11. Genmab A/S - R1507 Antibody to Enter Phase II Study to Treat Sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... DES MOINES, Iowa (PRWEB) July 23, 2014 ... will join the business as vice president of Agricultural ... from Mendel Biotechnology where he served most recently as ... brings extensive biotechnology and business leadership in the seed ... DuPont Pioneer,” said Paul E. Schickler , president ...
(Date:7/23/2014)... 2014  Sofinnova Ventures, a Menlo Park ... of Sofinnova Venture Partners IX, L.P. at the hard ... initial fund target of $425 million. Sofinnova ... Consistent with recent funds, SVP IX will provide capital ... along with select investments in earlier stage opportunities. Investments ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Adult ... transplant therapies are biological, but not magical. ... seem to treat them as if they were ... as unsanctioned studies that constitute “stem cell tourism,” ... an approach to developing new regenerative medicine therapies. ...
(Date:7/22/2014)... the National Institute of Standards and Technology (NIST) ... a new design for an atomic clock that ... a microcomb. , The microcomb clock, featured on ... new journal Optica ,* is the first ... its accurate conversion of optical frequencies to lower ...
Breaking Biology Technology:DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3Sofinnova Raises $500 Million Biotech Venture Fund 2The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 2The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 4The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 5'Comb on a chip' powers new NIST/Caltech atomic clock design 2
... industrial design at the Milwaukee Institute of Art and ... will assist people with spinal damage with their toileting activities. ... are paralyzed from the neck or the waist down can ... moving their bowels. Since they have no sensation in the ...
... , Milwaukee OnCourse Technologies , a ... have signed a term sheet to sell two subsidiaries to ... are involved in CAD/CAM technology: TekSoft creates the ... and distributor of related products. The deal is expected to ...
... researchers have put enough monitoring equipment on a bicycle to ... soap bubbles, and found losing sleep makes you hungry. Interested? ... ,Put a GPS monitor on a bicycle, add devices ... and rhythm created by their peddling, record it all at ...
Cached Biology Technology:This wheelchair will save lives 2This wheelchair will save lives 3Tech Digest: OnCourse, Menasha, Fiserv, Rockwell 2A week in UW research: fusion, racing and sleep 2A week in UW research: fusion, racing and sleep 3
(Date:7/23/2014)... -- The potential for clinical use of induced ... strategies has previously been hindered by the risk ... tumors. The ability to use etoposide treatment to ... of heart disease, specifically acute myocardial infarction, is ... and Development , a peer-reviewed journal from Mary ...
(Date:7/23/2014)... mollusks, starfish, and corals have in common? Aside ... calcifiersorganisms that use calcium from their environment to ... and protection. , The July issue of ... Biological Laboratory, addresses the challenges faced by these ... atmospheric carbon dioxide rises, the world,s oceans are ...
(Date:7/23/2014)... -- BCC Research ( www.bccresearch.com ... AND TECHNOLOGIES FOR SENSORS , the global market for ... nearly $154.4 billion by 2020, with a five-year compound ... and level sensors segment is moving at a significant ... , Sensors have become indispensable to many ...
Breaking Biology News(10 mins):Calcification in changing oceans explored in special issue of The Biological Bulletin 2Global Market for Sensors to Reach Nearly $154.4 Billion in 2020; Image Sensors Moving at 11.7% 2Global Market for Sensors to Reach Nearly $154.4 Billion in 2020; Image Sensors Moving at 11.7% 3
... six-month study by Iowa State University researchers had indicated ... isoflavones, lessened lumbar spine bone loss in midlife, perimenopausal ... of those same researchers does not show a bone-sparing ... except for a modest effect at the femoral (hip) ...
... 5, 2010) New research from the Hood Center for Children ... time sheds light on the significant potential negative impact that ... children. The study, which appears in the current edition ... the "brand placements" for food, beverage, and food retail establishments ...
... ( T. gondii ) is considered as one of the ... wide range of intermediate hosts, including all mammals and birds. ... and 20% in the world are chronically infected. ... now accepting applications for its Investigative Workshop, Modeling Toxoplasma ...
Cached Biology News:Multicenter study finds little effect of soy isoflavones on bone loss in postmenopausal women 2Multicenter study finds little effect of soy isoflavones on bone loss in postmenopausal women 3New study examines the impact on children of food product placements in the movies 2New study examines the impact on children of food product placements in the movies 3Modeling Toxoplasma focus of workshop 2
Human Carnosine Dipeptidase 1 Affinity Purified PAb...
... Interactions between P-selectin and P-selectin glycoprotein ligand-1 ... on the lumenal surface of endothelial cells ... the primary role of PSGL-1 in mediating ... been well documented.MAB4092 completely blocks recognition of ...
Mouse Anti-Human MCAF-(MCP-1)...
Mouse VEGF R1/Flt-1 Phycoerythrin MAb (Clone 141522) Keywords: Receptor Tyrosine Kinase, RTK, VEGFR1, VEGF Receptor 1 Protein Family: Receptor Tyrosine Kinases, VEGF/PDGF Family...
Biology Products: